DE69332977D1 - Thiolprotease enthaltender impfstoff - Google Patents

Thiolprotease enthaltender impfstoff

Info

Publication number
DE69332977D1
DE69332977D1 DE69332977T DE69332977T DE69332977D1 DE 69332977 D1 DE69332977 D1 DE 69332977D1 DE 69332977 T DE69332977 T DE 69332977T DE 69332977 T DE69332977 T DE 69332977T DE 69332977 D1 DE69332977 D1 DE 69332977D1
Authority
DE
Germany
Prior art keywords
thiolprotase
vaccine containing
fluke
cathepsin
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69332977T
Other languages
English (en)
Other versions
DE69332977T2 (de
Inventor
John Pius Dalton
Stuart Andrews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929222156A external-priority patent/GB9222156D0/en
Application filed by Individual filed Critical Individual
Publication of DE69332977D1 publication Critical patent/DE69332977D1/de
Application granted granted Critical
Publication of DE69332977T2 publication Critical patent/DE69332977T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69332977T 1992-10-21 1993-10-21 Thiolprotease enthaltender impfstoff Expired - Fee Related DE69332977T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9222156 1992-10-21
GB929222156A GB9222156D0 (en) 1992-10-21 1992-10-21 Vaccine
GB939307028A GB9307028D0 (en) 1992-10-21 1993-04-02 Vaccine
GB9307028 1993-04-02
PCT/GB1993/002172 WO1994009142A1 (en) 1992-10-21 1993-10-21 Vaccine containing a thiol protease

Publications (2)

Publication Number Publication Date
DE69332977D1 true DE69332977D1 (de) 2003-06-18
DE69332977T2 DE69332977T2 (de) 2004-05-19

Family

ID=26301834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332977T Expired - Fee Related DE69332977T2 (de) 1992-10-21 1993-10-21 Thiolprotease enthaltender impfstoff

Country Status (12)

Country Link
US (2) US6623735B1 (de)
EP (1) EP0666919B1 (de)
JP (1) JPH08502404A (de)
AT (1) ATE240397T1 (de)
AU (1) AU5340094A (de)
CA (1) CA2147378A1 (de)
DE (1) DE69332977T2 (de)
DK (1) DK0666919T3 (de)
ES (1) ES2199947T3 (de)
NZ (1) NZ257148A (de)
PT (1) PT666919E (de)
WO (1) WO1994009142A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795768A (en) * 1991-02-12 1998-08-18 Heska Corporation Filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
US6419923B1 (en) 1991-02-12 2002-07-16 Heska Corporation Filariid nematode cysteine protease proteins, and uses thereof
WO1994017820A1 (en) * 1993-02-05 1994-08-18 Daratech Pty. Ltd. Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same
GB9312324D0 (en) * 1993-06-15 1993-07-28 Pitman Moore Inc Vaccine
AU702915B2 (en) * 1994-05-26 1999-03-11 Heska Corporation Novel parasite protease genes and proteins
GB9419969D0 (en) * 1994-10-04 1994-11-16 Mallinckrodt Veterinary Inc Vaccine
GB9612214D0 (en) 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
WO1998040497A2 (en) 1997-03-11 1998-09-17 Stichting Dienst Landbouwkundig Onderzoek An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
EP2485725A2 (de) 2009-10-07 2012-08-15 Wyeth LLC Zusammensetzungen mit adjuvanzien, makroliden und proteinösen antigenen sowie verwendungsverfahren dafür

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
JPH04507235A (ja) * 1989-01-31 1992-12-17 ダラテック　ピーテーワイ　リミテッド 反芻動物における肝吸虫感染に対する予防治療のためのワクチン
CA2123420A1 (en) * 1991-11-12 1993-05-27 Robert B. Grieve Protease vaccine against heartworm
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
ATE240397T1 (de) 2003-05-15
CA2147378A1 (en) 1994-04-28
EP0666919B1 (de) 2003-05-14
WO1994009142A1 (en) 1994-04-28
EP0666919A1 (de) 1995-08-16
DE69332977T2 (de) 2004-05-19
JPH08502404A (ja) 1996-03-19
DK0666919T3 (da) 2003-09-08
US20050208063A1 (en) 2005-09-22
NZ257148A (en) 1996-04-26
ES2199947T3 (es) 2004-03-01
PT666919E (pt) 2003-09-30
US6623735B1 (en) 2003-09-23
AU5340094A (en) 1994-05-09

Similar Documents

Publication Publication Date Title
DK0656888T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfonamider, anvendelige som retrovirale protease-inhibitorer
ATE112958T1 (de) Emulsionen von perfluorhaltigen organischen verbindungen.
ATE148113T1 (de) Retrovirale protease inhibitoren, enthaltend cyclische sulfone
ATE377006T1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
NO302883B1 (no) N-(alkanoylamino-2-hydroksypropyl)-sulfonamider som er nyttige som retrovirale proteaseinhibitorer, samt preparater inneholdene forbindelsene
ATE296626T1 (de) Retrovirusprotease inhibitoren
ES2150933T3 (es) Inhibidores de la proteasa vih utiles para el tratamiento del sida.
ATE196466T1 (de) Inhibitoren retroviraler proteasen
DE69332977D1 (de) Thiolprotease enthaltender impfstoff
DE69326077T2 (de) Sulfonylalkanoylaminohydroxyethylaminosulfaminsäuren verwendbar als inhibitoren retroviraler proteasen
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
FI884955A (fi) Konserverade haor- och hudrengoeringsmedel och anvaendning av en konserveringsmedelkombination.
DE69737500D1 (de) Von willebrand-faktor multimerase
DK0703789T3 (da) Vaccine indeholdende en serinprotease
BE876296A (fr) Compositions pharmaceutiques contenant des prostaglandines
ATE158304T1 (de) Dithiolanylglycinhaltige hiv-proteaseinhibitoren vom hydroxyethylenisostertyp
NO950897L (no) Inhibisjon av retro virusinfeksjon
KR950700685A (ko) 최음제로서 사용되는 요드화수소산(use of hydriodic acid as an aphrodisiac)
PT878195E (pt) Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
ES2067140T3 (es) Compuestos fenilester de acido benzoico y composiciones inhibidoras de la elastasa que contienen los mismos.
GR1001368B (el) Φαρμακευτικοί φορείς.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee